Hong Kong-based Insilico Medicine, an artificial intelligence company, has secured $37 million in funding. Qiming Venture Partners led the round with participation from other investors that included Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital and BOLD Capital Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.